2-methyl-1,3,4,14b-tetrahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepin-10(2H)-one;1,3,4,14b-Tetrahydro-2-methyl-pyrazino[2,1-a]pyrido[2,3-c][2]benzazepin-10(2H)-one;Mirtazapine Impurity F; USP Mirtazapine Related Compound D; Mirtazapine EP Impurity F;10-Oxo Mirtazapine (Mirtazapine Impurity F); (10-Oxo Mirtazapine)
Mirtazapine EP Impurity F is a fully characterized chemical compound used as a reference standard of API Mirtazapine. The standard offered is compliant with regulatory guidelines. Mirtazapine EP Impurity F is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 191546-97-1
Related products
Mirtazapine-13C-d3 HCl
M.F.
M.W. 269.37 36.46
CAT# AR-M02040
CAS# 85650-52-8 (non-labelled and free base)
